STOCK TITAN

VTRS Director Form 3 Filed — No Beneficial Ownership Reported

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Viatris Inc. (VTRS) Form 3 reports that David S. Simmons, identified as a Director, filed an initial beneficial ownership statement related to an event on 08/04/2025. The filing lists Mr. Simmons's address as 1000 Mylan Boulevard, Canonsburg, PA 15317. The form discloses no securities are beneficially owned by the reporting person. The document is signed on behalf of the reporting person by Kevin D. Macikowski, by power of attorney with a signature date of 08/13/2025. No derivative or non-derivative holdings, amendments, or additional relationships are reported beyond the director designation.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
SIMMONS DAVID S

(Last) (First) (Middle)
1000 MYLAN BOULEVARD

(Street)
CANONSBURG PA 15317

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/04/2025
3. Issuer Name and Ticker or Trading Symbol
Viatris Inc [ VTRS ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Exhibit 24 - Power of Attorney
No securities are beneficially owned.
/s/ Kevin D. Macikowski, by power of attorney 08/13/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Viatris (VTRS) Form 3 filed by David S. Simmons disclose?

The Form 3 states that David S. Simmons is a Director and that he owns no securities of Viatris as of the reported event date 08/04/2025.

When was the event triggering the Form 3 for VTRS reported?

The event date listed on the Form 3 is 08/04/2025, and the form was signed via power of attorney on 08/13/2025.

Who signed the Form 3 for David S. Simmons on the Viatris filing?

The filing is signed as /s/ Kevin D. Macikowski, by power of attorney with the signature date 08/13/2025.

Does the Form 3 list any derivative securities or options for VTRS?

No. The Form 3 explicitly states no securities are beneficially owned and includes no entries for derivative or non-derivative securities.

What address is provided for the reporting person on the VTRS Form 3?

The address shown is 1000 Mylan Boulevard, Canonsburg, PA 15317.
Viatris Inc Ord Shs

NASDAQ:VTRS

View VTRS Stock Overview

VTRS Rankings

VTRS Latest News

VTRS Latest SEC Filings

VTRS Stock Data

15.38B
1.15B
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CANONSBURG